Sfoglia per AUTORE
REMON J
Collezione AOU San Luigi di Orbassano

  

Items : 11

Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Jan 17;31(2):352-364. doi: 10.1158/1078-0432.CCR-24-1993.
2025
AOU San Luigi di Orbassano

Dall'Olio FG; Zrafi W; Roelants V; Ambrosini V; Fourquet A; Mitea C; Passiglia F; Bauckneht M; Bonardel G; Conci N; Benitez JC; Arena V; Namour C; Naigeon M; Monnet I; Beshiri K; Hoton D; Dursun S; Danlos FX; Argalia G; Aldea M; Rovera G; Derosa L; Iebba V; Gietema HA; Gounant V; Lacroix V; Remon J; Gautheret D; et alii...

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Planchard D; Besse B; Novello S; Barlesi F; Le Péchoux C; Facchinetti F; Aldea M; Genova C; Bironzo P; Di Maio M; Remon J; Tagliamento M; Tagliamento M; Di Maio M; Remon J; Bironzo P; Genova C; Facchinetti F; Aldea M; Le Péchoux C; Novello S; Barlesi F; Besse B; Planchard D;

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey. in JTO clinical and research reports / JTO Clin Res Rep. 2022 Dec 15;4(1):100446. doi: 10.1016/j.jtocrr.2022.100446. eCollection 2023 Jan.
2023
AOU San Luigi di Orbassano

Novello S; Besse B; Bironzo P; De Maria A; Giaj Levra M; Remon J; Tagliamento M; Mezquita L;

2022
AOU San Luigi di Orbassano

Remon J; Girard N; Novello S; de Castro J; Bigay-Game L; Bernabé R; Greillier L; Mosquera J; Cousin S; Juan O; Sampayo M; Besse B; Remon J; Girard N; Novello S; de Castro J; Bigay-Game L; Bernabé R; Greillier L; Mosquera J; Cousin S; Juan O; Sampayo M; Besse B;

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Jul;169:94-101. doi: 10.1016/j.lungcan.2022.05.009. Epub 2022 May 19.
2022
AOU San Luigi di Orbassano

Pilotto S; Avancini A; Menis J; Sperduti I; Giaj Levra M; Berghmans T; Bironzo P; Brandão M; De Ruysscher D; Edwards J; Faivre-Finn C; Girard N; Greillier L; Hendriks L; Lantuejoul S; Mauer M; Novello S; O'Brien M; Reck M; Reguart N; Remon J; von der Thüsen J; Dingemans AC; Besse B; Milella M;

Malignant pleural mesothelioma: new guidelines make us stronger for defeating this disease. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Feb;33(2):123-125. doi: 10.1016/j.annonc.2021.11.019. Epub 2021 Dec 6.
2022
AOU San Luigi di Orbassano

Remon J; Hendriks LEL; Bironzo P; Remon J; Hendriks LEL; Bironzo P;

Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102250. doi: 10.1016/j.ctrv.2021.102250. Epub 2021 Jun 16.
2021
AOU San Luigi di Orbassano

Parikh K; Hendriks LEL; Bironzo P; Remon J;

Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer. in Cancer treatment reviews / Cancer Treat Rev. 2021 Apr;95:102178. doi: 10.1016/j.ctrv.2021.102178. Epub 2021 Mar 10.
2021
AOU San Luigi di Orbassano

Remon J; Pignataro D; Novello S; Passiglia F;

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2020 Jun;15(6):914-947. doi: 10.1016/j.jtho.2020.03.006. Epub 2020 Mar 14.
2020
AOU San Luigi di Orbassano

Remon J; Passiglia F; Ahn MJ; Barlesi F; Forde PM; Garon EB; Gettinger S; Goldberg SB; Herbst RS; Horn L; Kubota K; Lu S; Mezquita L; Paz-Ares L; Popat S; Schalper KA; Skoulidis F; Reck M; Adjei AA; Scagliotti GV;

Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ?1% by the USA Food and Drug Administration. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2019 Nov 1;30(11):1686-1688. doi: 10.1093/annonc/mdz295.
2019
AOU San Luigi di Orbassano

Mountzios G; Remon J; Novello S; Blais N; Califano R; Cufer T; Dingemans AM; Liu SV; Peled N; Pennell NA; Reck M; Rolfo C; Tan D; Vansteenkiste J; West H; Besse B;

The APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR-mutant NSCLC Patients. EORTC 1613. in Clinical lung cancer / Clin Lung Cancer. 2017 Sep;18(5):583-588. doi: 10.1016/j.cllc.2017.02.005. Epub 2017 Mar 1.
2017
AOU San Luigi di Orbassano

Remon J; Menis J; Hasan B; Peric A; De Maio E; Novello S; Reck M; Berghmans T; Wasag B; Besse B; Dziadziuszko R;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte